Where to Initiate Basal Insulin Therapy: Inpatient or Outpatient Department? Real-World Observation in China

References

• Wang L, Gao P, Zhang M, et al. Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013. JAMA. 2017;317(24):2515–2523. doi:10.1001/jama.2017.7596
   PubMed Web of Science ®Google Scholar
• Jia W, Weng J, Zhu D, et al. Standards of medical care for type 2 diabetes in China 2019. Diabetes Metab Res Rev. 2019;35(6):e3158. doi:10.1002/dmrr.3158
   PubMed Web of Science ®Google Scholar
• American Diabetes A. 9. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2020. Diabetes Care. 2020;43(Suppl 1):S98–S110. doi:10.2337/dc20-S009
   PubMed Web of Science ®Google Scholar
• Group UPDSU. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837–853. doi:10.1016/S0140-6736(98)07019-6
   Web of Science ®Google Scholar
• Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract. 1995;28(2):103–117. doi:10.1016/0168-8227(95)01064-K
   PubMed Web of Science ®Google Scholar
• Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577–1589. doi:10.1056/NEJMoa0806470
   PubMed Web of Science ®Google Scholar
• Tibaldi J, Rakel RE. Why, when and how to initiate insulin therapy in patients with type 2 diabetes. Int J Clin Pract. 2007;61(4):633–644. doi:10.1111/j.1742-1241.2007.01309.x
   Web of Science ®Google Scholar
• Hsia E, Draznin B. Intensive control of diabetes in the hospital: why, how, and what is in the future? J Diabetes Sci Technol. 2011;5(6):1596–1601. doi:10.1177/193229681100500637
   Google Scholar
• Shogbon AO, Levy SB. Intensive glucose control in the management of diabetes mellitus and inpatient hyperglycemia. Am J Health Syst Pharm. 2010;67(10):798–805. doi:10.2146/ajhp090211
   PubMed Web of Science ®Google Scholar
• Hayes RP, Fitzgerald JT, Jacober SJ. Primary care physician beliefs about insulin initiation in patients with type 2 diabetes. Int J Clin Pract. 2008;62(6):860–868. doi:10.1111/j.1742-1241.2008.01742.x
   PubMed Web of Science ®Google Scholar
• Cuddihy RM, Philis-Tsimikas A, Nazeri A. Type 2 diabetes care and insulin intensification: is a more multidisciplinary approach needed? Results from the MODIFY survey. Diabetes Educ. 2011;37(1):111–123. doi:10.1177/0145721710388426
   PubMed Web of Science ®Google Scholar
• Ji L, Zhang P, Weng J, et al. Observational Registry of Basal Insulin Treatment (ORBIT) in Patients with type 2 diabetes uncontrolled by oral hypoglycemic agents in China--Study design and baseline Characteristics. Diabetes Technol Ther. 2015;17(10):735–744. doi:10.1089/dia.2015.0054
   Web of Science ®Google Scholar
• Seaquist ER, Anderson J, Childs B, et al. Hypoglycemia and diabetes: a report of a workgroup of the American diabetes association and the endocrine society. Diabetes Care. 2013;36(5):1384–1395. doi:10.2337/dc12-2480
   PubMed Web of Science ®Google Scholar
• Kim SS, Kim IJ, Kim YK, et al. Insulin initiation in insulin-naive Korean type 2 diabetic patients inadequately controlled on oral antidiabetic drugs in real-world practice: the modality of insulin treatment evaluation study. Diabetes Metab J. 2015;39(6):481–488. doi:10.4093/dmj.2015.39.6.481
   Web of Science ®Google Scholar
• Patrick AR, Fischer MA, Choudhry NK, et al. Trends in insulin initiation and treatment intensification among patients with type 2 diabetes. J Gen Intern Med. 2014;29(2):320–327. doi:10.1007/s11606-013-2643-6
   PubMed Web of Science ®Google Scholar
• Owens DR, Luzio SD, Sert-Langeron C, Riddle MC. Effects of initiation and titration of a single pre-prandial dose of insulin glulisine while continuing titrated insulin glargine in type 2 diabetes: a 6-month ‘proof-of-concept’ study. Diabetes Obes Metab. 2011;13(11):1020–1027. doi:10.1111/j.1463-1326.2011.01459.x
   PubMed Web of Science ®Google Scholar
• Blackberry ID, Furler JS, Ginnivan LE, et al. An exploratory trial of basal and prandial insulin initiation and titration for type 2 diabetes in primary care with adjunct retrospective continuous glucose monitoring: INITIATION study. Diabetes Res Clin Pract. 2014;106(2):247–255. doi:10.1016/j.diabres.2014.08.011
   Web of Science ®Google Scholar
• Tsai ST, Pathan F, Ji L, et al. First insulinization with basal insulin in patients with Type 2 diabetes in a real-world setting in Asia. J Diabetes. 2011;3(3):208–216. doi:10.1111/j.1753-0407.2011.00137.x
   PubMed Web of Science ®Google Scholar
• Orozco-Beltran D, Pan C, Svendsen AL, Faerch L, Caputo S. Basal insulin initiation in primary vs. specialist care: similar glycaemic control in two different patient populations. Int J Clin Pract. 2016;70(3):236–243. doi:10.1111/ijcp.12776
   Web of Science ®Google Scholar
• Perez-Nieves M, Kabul S, Desai U, et al. Basal insulin persistence, associated factors, and outcomes after treatment initiation among people with type 2 diabetes mellitus in the US. Curr Med Res Opin. 2016;32(4):669–680. doi:10.1185/03007995.2015.1135789
   PubMed Web of Science ®Google Scholar
• Wei W, Pan C, Xie L, Baser O. Real-world insulin treatment persistence among patients with type 2 diabetes. Endocr Pract. 2014;20(1):52–61. doi:10.4158/EP13159.OR
   PubMed Web of Science ®Google Scholar
• Yavuz DG, Ozcan S, Deyneli O. Adherence to insulin treatment in insulin-naive type 2 diabetic patients initiated on different insulin regimens. Patient Prefer Adherence. 2015;9:1225–1231. doi:10.2147/PPA.S87935
   PubMed Web of Science ®Google Scholar
• Roussel R, Charbonnel B, Behar M, Gourmelen J, Emery C, Detournay B. Persistence with Insulin Therapy in Patients with Type 2 Diabetes in France: An Insurance Claims Study. Diabetes Ther. 2016;7(3):537–549. doi:10.1007/s13300-016-0185-8
   Web of Science ®Google Scholar
• Rodbard HW, Visco VE, Andersen H, Hiort LC, Shu DH. Treatment intensification with stepwise addition of prandial insulin aspart boluses compared with full basal-bolus therapy (FullSTEP Study): a randomised, treat-to-target clinical trial. Lancet Diabetes Endocrinol. 2014;2(1):30–37. doi:10.1016/S2213-8587(13)70090-1
   Web of Science ®Google Scholar
• Abrahamson MJ, Peters A. Intensification of insulin therapy in patients with type 2 diabetes mellitus: an algorithm for basal-bolus therapy. Ann Med. 2012;44(8):836–846. doi:10.3109/07853890.2012.699715
   PubMed Web of Science ®Google Scholar
• Zhu D. Clinical recommendation of insulin therapy evolution after insulin initiation for patients with type 2 diabetes. Chin J Diabetes. 2018;10(02):97–102.
   Google Scholar
• Khunti K, Millar-Jones D. Clinical inertia to insulin initiation and intensification in the UK: A focused literature review. Prim Care Diabetes. 2017;11(1):3–12. doi:10.1016/j.pcd.2016.09.003
   PubMed Web of Science ®Google Scholar
• LaSalle JR. Empowering patients during insulin initiation: a real-world approach. J Am Osteopath Assoc. 2010;110(2):69–78.
   Google Scholar